Ticker: TSHA

Company: Taysha Gene Therapies, Inc.

Person: Sukumar Nagendran, director, officer

Transaction date: April 10, 2026

Reporting date: April 13, 2026

Average share price: 4.7490266273987585

Sold 180979.0 shares for 859474.09